Tranexamic acid (TXA) is a popular antifibrinolytic drug widely used in hemorrhagic trauma
patients and cardiovascular, orthopedic, and gynecological surgical patients. TXA binds …

Objective To conduct a systematic review and meta-analysis of all randomized controlled
trials (RCTs) that inspected the efficacy and safety of prophylactic TXA compared with …

Objective To conduct a systematic review and meta-analysis of randomized controlled trials
on the clinical efficacy and safety of prophylactic tranexamic acid (TXA) versus control …

Background There is evidence that tranexamic acid (TXA) reduces surgical bleeding and is
widely used in trauma, obstetrics and other specialties. This practice is less well-established …

To perform a systematic review and meta-analysis of all randomized controlled trials (RCTs)
that evaluated the efficacy and safety of prophylactic tranexamic acid (TXA) versus a control …

Introduction Tranexamic acid has been widely used in plastic surgery. However, its efficacy
has yet to be fully established. This meta-analysis aimed to determine its effectiveness in …

Background Hyperthermic intraperitoneal chemotherapy (HIPEC), following cytoreductive
surgery (CRS), is a lengthy procedure, usually associated with considerable bleeding due to …

Introduction Tranexamic acid (TXA) is a potent antifibrinolytic drug that inhibits the activation
of plasmin by plasminogen. While not a new medication, TXA has quickly gained traction …

Objectives Perioperative bleeding poses a significant issue during thoracic surgery.
Tranexamic acid (TXA) is one of the most commonly used antifibrinolytic agents for surgical …

Objective This study aims to characterize current use, knowledge, and attitude toward ERAS
protocols by academic craniofacial surgeons. Design Craniofacial surgeons were provided …